EpimAb Biotherapeutics
岸迈生物
EpimAb Biotherapeutics
Biotech/Healthcare
EpimAb Biotherapeutics is an emerging innovative biopharmaceutical R&D company headquartered in Zhangjiang Hi-Tech Park, Pudong, Shanghai. Its proprietary FIT-Ig® technology is a unique and highly efficient platform for developing bispecific antibody products.
Latest round: Series C (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.